Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Tamoxifen 3Radiotherapy 3Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Radiation 2Observation 2Metformin 2pembrolizumab 1exemestane 1afimoxifene 1Tablets 1Surgical Procedures, Operative 1Steroids 1Specimen Handling 1Protons 1Proton Therapy 1Petrolatum 1Nutrition Assessment 1Neoadjuvant Therapy 1Mastectomy, Segmental 1Mammography 1Magnetic Resonance Spectroscopy 1Letrozole 1Biopsy, Needle 1Biopsy, Large-Core Needle 1Anastrozole 14,17 beta-dihydroxy-4-androstene-3-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma, Intraductal, Noninfiltrating × afimoxifene × Clear all
NCT04009044 2025-10-09

Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

Northwestern University

Phase 2 Active not recruiting
156 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡